NCT02926742View on ClinicalTrials.gov

Submassive Pulmonary Embolism Experience With EKOS

UnknownOBSERVATIONAL

Enrollment

50

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 28, 2017

Study Completion Date

February 28, 2017

Conditions

Thrombolytic TherapyThrombolysisMechanical ThrombolysisPulmonary Embolism

Interventions

DEVICE

EkoSonic Endovascular System

Ultrasound catheter-directed thrombolysis.

Trial Locations (1)

43130

RECRUITING

Fairfield Medical Center, Lancaster

Sponsors

Collaborators (1)

EKOS Corporation

All Listed Sponsors

collaborator

EKOS Corporation

INDUSTRY

lead

Krishna Mannava, MD, FACS, RPVI

OTHER

NCT02926742 - Submassive Pulmonary Embolism Experience With EKOS | Biotech Hunter | Biotech Hunter